| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Znf_PHD-finger | 8.07e-06 | 79 | 65 | 5 | IPR019787 | |
| Domain | PHD | 1.45e-05 | 89 | 65 | 5 | SM00249 | |
| Domain | Znf_PHD | 1.61e-05 | 91 | 65 | 5 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.99e-05 | 95 | 65 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 2.09e-05 | 96 | 65 | 5 | PS01359 | |
| Domain | - | 2.40e-05 | 449 | 65 | 9 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 2.85e-05 | 459 | 65 | 9 | IPR013083 | |
| Domain | PHD | 1.35e-04 | 75 | 65 | 4 | PF00628 | |
| Domain | Znf_FYVE_PHD | 1.59e-04 | 147 | 65 | 5 | IPR011011 | |
| Domain | zf-RING_2 | 7.87e-04 | 52 | 65 | 3 | PF13639 | |
| Domain | EPHD | 2.63e-03 | 22 | 65 | 2 | PS51805 | |
| Domain | PH | 2.81e-03 | 278 | 65 | 5 | SM00233 | |
| Domain | PH_domain | 2.90e-03 | 280 | 65 | 5 | IPR001849 | |
| Domain | ZF_RING_1 | 3.42e-03 | 291 | 65 | 5 | PS00518 | |
| Domain | ZF_RING_2 | 3.78e-03 | 298 | 65 | 5 | PS50089 | |
| Domain | RING | 4.17e-03 | 305 | 65 | 5 | SM00184 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RNF223 EPS15L1 KMT2D PCNX3 SZT2 PPRC1 SPEG INPPL1 SEC16A DISP2 MLLT6 CACNA1H CABIN1 ZNF503 | 2.99e-08 | 1105 | 69 | 14 | 35748872 |
| Pubmed | PHF1 CUX2 ZNF775 PER3 PIAS3 GLIS2 GATA3 MLLT6 BRD3 ZFP36 ARID3B | 5.32e-07 | 808 | 69 | 11 | 20412781 | |
| Pubmed | ZNF503/Zpo2 drives aggressive breast cancer progression by down-regulation of GATA3 expression. | 3.88e-06 | 2 | 69 | 2 | 28258171 | |
| Pubmed | ZNF503 combined with GATA3 is a prognostic factor in triple-negative breast cancer. | 3.88e-06 | 2 | 69 | 2 | 37036735 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 37819540 | ||
| Pubmed | Restraint of IFN-γ expression through a distal silencer CNS-28 for tissue homeostasis. | 3.88e-06 | 2 | 69 | 2 | 37040761 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 26970513 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 20236936 | ||
| Pubmed | 1.47e-05 | 24 | 69 | 3 | 33722704 | ||
| Pubmed | 1.65e-05 | 407 | 69 | 7 | 12693553 | ||
| Pubmed | 2.11e-05 | 27 | 69 | 3 | 19026994 | ||
| Pubmed | Extended interaction network of procollagen C-proteinase enhancer-1 in the extracellular matrix. | 2.32e-05 | 4 | 69 | 2 | 24117177 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 38614090 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 8896557 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 20221403 | ||
| Pubmed | 8.02e-05 | 709 | 69 | 8 | 22988430 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.41e-04 | 398 | 69 | 6 | 35016035 | |
| Pubmed | 1.64e-04 | 1006 | 69 | 9 | 15226823 | ||
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 24778262 | ||
| Pubmed | VPS9D1 EPS15L1 PIAS3 PPRC1 MAST1 CABIN1 ZFP36 SH2B1 CREBZF AGAP2 | 2.14e-04 | 1285 | 69 | 10 | 35914814 | |
| Pubmed | 2.91e-04 | 645 | 69 | 7 | 25281560 | ||
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 2.98e-04 | 13 | 69 | 2 | 17761849 | |
| Pubmed | 3.41e-04 | 469 | 69 | 6 | 27634302 | ||
| Pubmed | 3.48e-04 | 14 | 69 | 2 | 32541010 | ||
| Pubmed | KMT2D SEC16A GATA3 KDM2B MLLT6 PROSER1 ELK4 CABIN1 ZNF503 ARID3B | 4.97e-04 | 1429 | 69 | 10 | 35140242 | |
| Pubmed | KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation. | 5.18e-04 | 17 | 69 | 2 | 26932671 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 5.31e-04 | 79 | 69 | 3 | 12679517 | |
| Pubmed | 6.13e-04 | 83 | 69 | 3 | 28794006 | ||
| Pubmed | Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. | 6.49e-04 | 19 | 69 | 2 | 30385546 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 6.74e-04 | 351 | 69 | 5 | 38297188 | |
| Pubmed | 7.20e-04 | 20 | 69 | 2 | 24385915 | ||
| Pubmed | 7.20e-04 | 20 | 69 | 2 | 30596474 | ||
| Pubmed | Pax9 and Jagged1 act downstream of Gli3 in vertebrate limb development. | 7.20e-04 | 20 | 69 | 2 | 16169709 | |
| Pubmed | 7.78e-04 | 549 | 69 | 6 | 38280479 | ||
| Pubmed | 7.95e-04 | 21 | 69 | 2 | 22219353 | ||
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 7.95e-04 | 21 | 69 | 2 | 27626377 | |
| Pubmed | OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. | 8.01e-04 | 91 | 69 | 3 | 30472188 | |
| Pubmed | 8.07e-04 | 209 | 69 | 4 | 36779422 | ||
| Pubmed | 8.27e-04 | 92 | 69 | 3 | 20368287 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 8.58e-04 | 774 | 69 | 7 | 15302935 | |
| Pubmed | CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP. | 8.73e-04 | 22 | 69 | 2 | 34187934 | |
| Pubmed | Functional synergy between cholecystokinin receptors CCKAR and CCKBR in mammalian brain development. | 9.55e-04 | 23 | 69 | 2 | 25875176 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 9.70e-04 | 573 | 69 | 6 | 28330616 | |
| Pubmed | 1.04e-03 | 24 | 69 | 2 | 34215813 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.08e-03 | 101 | 69 | 3 | 20551380 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.17e-03 | 231 | 69 | 4 | 16452087 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.31e-03 | 608 | 69 | 6 | 36089195 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.52e-03 | 248 | 69 | 4 | 24006456 | |
| Pubmed | 1.52e-03 | 29 | 69 | 2 | 26097038 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.66e-03 | 430 | 69 | 5 | 35044719 | |
| Pubmed | c-Jun is required for the specification of joint cell fates. | 1.74e-03 | 31 | 69 | 2 | 23475960 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.76e-03 | 877 | 69 | 7 | 20211142 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.78e-03 | 259 | 69 | 4 | 30404004 | |
| Pubmed | 1.97e-03 | 33 | 69 | 2 | 19336002 | ||
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 1.97e-03 | 33 | 69 | 2 | 26864203 | |
| GeneFamily | PHD finger proteins | 5.36e-06 | 90 | 51 | 5 | 88 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 1.43e-05 | 199 | 69 | 6 | M9443 | |
| Coexpression | GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN | 1.47e-05 | 200 | 69 | 6 | M4878 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.39e-06 | 178 | 69 | 5 | 50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_TRM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.85e-06 | 184 | 69 | 5 | 17ffa0e890960c00a3b5fa33d48caba66c61dbb0 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-05 | 187 | 69 | 5 | 150023e6a50c9da461f2321074d2d5e96caafb06 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_follicular_helper_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.21e-05 | 192 | 69 | 5 | 3e2a0f332e7f9833ba88f3c809cee78b65090401 | |
| ToppCell | mild_COVID-19-MAIT|World / disease group, cell group and cell class (v2) | 1.30e-05 | 195 | 69 | 5 | 74f0f709d9b3eed5d7e02a51884f02cc281782f1 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-05 | 199 | 69 | 5 | 20f760d92c351a1dac4cc0a424c443ea03a179fe | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_activated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.14e-05 | 124 | 69 | 4 | e16be7805c91db12b1110c90cd39492913f1d3ea | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.82e-05 | 141 | 69 | 4 | 737237db115721524c44ea4c55aed000e1b00ee5 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.82e-05 | 141 | 69 | 4 | c14f84bc3921cafbce6fa7f7163ecf3cd9cdf073 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.67e-05 | 150 | 69 | 4 | 207fc230d7721149c7afc7970dd56817f52801d8 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.90e-05 | 151 | 69 | 4 | 28e3f77d2edb30fcf1414762a55ceffaf879d526 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.90e-05 | 151 | 69 | 4 | 688cc5e4d46ba16f9b431352d7a6d39b21941e9c | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.90e-05 | 151 | 69 | 4 | 45392bb1c6358beff33da0ca84f7696fb5824f30 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.90e-05 | 151 | 69 | 4 | 3d861285c71abe220b19a069eb9876199c6c8f39 | |
| ToppCell | Mild_COVID-19-Myeloid-TRAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 9.60e-05 | 154 | 69 | 4 | ab648f6b29eb9e499e46cbdbaf3c5cf6b94d1f64 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.60e-05 | 154 | 69 | 4 | 874b1220337276489a89fcc9a39bc81ba6b68baf | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-04 | 156 | 69 | 4 | 8790b4b400695571fcf1ccb24c658b5e90854ff7 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.09e-04 | 159 | 69 | 4 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8+/CD4+_Mixed_Th|normal_Lymph_Node / Location, Cell class and cell subclass | 1.17e-04 | 162 | 69 | 4 | 12bd0b99aee13da60d0684a5e2a705824db1899c | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 165 | 69 | 4 | 66f0364098d82629aa2ec1dfe0c5ad23de7c2c12 | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 1.28e-04 | 166 | 69 | 4 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-04 | 168 | 69 | 4 | 55f328353119cbdc521c782ebb8d163876f4186d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-04 | 171 | 69 | 4 | 4fd2c7977c512c51507f055fc74b111c0228ed8b | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 1.54e-04 | 174 | 69 | 4 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 177 | 69 | 4 | f28243b51be104cb3adcde63f03fc2206ed3121e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 177 | 69 | 4 | 8887ff6341eb070bdaa890cc2cd7745f0cf1b0af | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 177 | 69 | 4 | 507f06d31ab773099c9431b6f433899dc97b5566 | |
| ToppCell | COPD-Myeloid-pDC|COPD / Disease state, Lineage and Cell class | 1.64e-04 | 177 | 69 | 4 | 415aa023195a7f961c09529f65cdcc7bb90eaf5d | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 1.68e-04 | 178 | 69 | 4 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-MAIT|bone_marrow / Manually curated celltypes from each tissue | 1.68e-04 | 178 | 69 | 4 | 7ac71e245864be2e8daecf555ff68235bd05827c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 179 | 69 | 4 | c9f45cfea0ceb0cdc31bcfd123aeab69aeb35c35 | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 179 | 69 | 4 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-04 | 179 | 69 | 4 | db76edd368eeca05a2a5d407c3eb2f535ade0ce3 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.79e-04 | 181 | 69 | 4 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.82e-04 | 182 | 69 | 4 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.82e-04 | 182 | 69 | 4 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.82e-04 | 182 | 69 | 4 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.82e-04 | 182 | 69 | 4 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 182 | 69 | 4 | ccfee33de0faebbe69099d4ff3c3971f6a708b99 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 1.86e-04 | 183 | 69 | 4 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|normal_Lung / Location, Cell class and cell subclass | 1.86e-04 | 183 | 69 | 4 | c930b957d16f9b0904b6c424acd914532e5cc137 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | 89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | 34c84ac9a32eaf96f45b79485119cad65905817d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 186 | 69 | 4 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-04 | 187 | 69 | 4 | f0c4d93f75615e570e4465fd622e3124189618a1 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-04 | 187 | 69 | 4 | 3ff57da09ed8394913fb683669d7bff84a936623 | |
| ToppCell | IPF-Stromal-SMC|World / Disease state, Lineage and Cell class | 2.06e-04 | 188 | 69 | 4 | b66264e8f8d536ed2beec31e6746c687718f239b | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Basophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.06e-04 | 188 | 69 | 4 | 3638d85452de15a060146628fbbad9d2a36feb13 | |
| ToppCell | IPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class | 2.06e-04 | 188 | 69 | 4 | e98b24c0de41285f01f7ac194ff0a1b59fd5c333 | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.06e-04 | 188 | 69 | 4 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 189 | 69 | 4 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | Striatum-Endothelial|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.11e-04 | 189 | 69 | 4 | 95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like|bone_marrow / Manually curated celltypes from each tissue | 2.11e-04 | 189 | 69 | 4 | ac2995e599f3d1813218479dc515b1d612c0ef8b | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.11e-04 | 189 | 69 | 4 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.15e-04 | 190 | 69 | 4 | a7f6c38bbf451f166febb21e6719d4afced4035e | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.19e-04 | 191 | 69 | 4 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-Treg|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.24e-04 | 192 | 69 | 4 | cd34defac6565d34db507918e791b09c79f7d1f8 | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 2.24e-04 | 192 | 69 | 4 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-04 | 192 | 69 | 4 | 71863f18a82394ed9f8e5ec8a4017215382a8284 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-04 | 192 | 69 | 4 | dee97f650ae6f4d07a142ade402aae1905791a22 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.28e-04 | 193 | 69 | 4 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.28e-04 | 193 | 69 | 4 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.33e-04 | 194 | 69 | 4 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 2.33e-04 | 194 | 69 | 4 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue | 2.37e-04 | 195 | 69 | 4 | 972b09697b7b66fb8a27dfc0c0b05a844121f055 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-04 | 195 | 69 | 4 | 7155cc12cc6a97efd626bbdb95249fb3d7041dcf | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-04 | 195 | 69 | 4 | a52ee3ad6cd317f10b9308450517861ef2e363bb | |
| ToppCell | mild_COVID-19-MAIT|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.37e-04 | 195 | 69 | 4 | b99815ec94042da1a2574468331b043d29d70b38 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-04 | 195 | 69 | 4 | b3660779f274ca97dd844cf83f62d85ba88cb182 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-04 | 195 | 69 | 4 | fbc324c3435f32b9ca269d83333faecfe940d7fe | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 2.37e-04 | 195 | 69 | 4 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|tumor_Lung / Location, Cell class and cell subclass | 2.37e-04 | 195 | 69 | 4 | ea9ff25020c2fcd1bab80e1829af0f4e4777de8b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.42e-04 | 196 | 69 | 4 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-04 | 196 | 69 | 4 | b10b386aacc672949560df2dbb0d4f76cf62e213 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 197 | 69 | 4 | 3f078be0b0f5e16edfb6d517beb20ac6178767f0 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 197 | 69 | 4 | d1cb30ec4f3024541e9876c70bf63fe4d5c55bf1 | |
| ToppCell | Biopsy_IPF-Immune-pDCs|Biopsy_IPF / Sample group, Lineage and Cell type | 2.52e-04 | 198 | 69 | 4 | aa8943e6796f619406056cf763b751fe9a9a3e0c | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-04 | 198 | 69 | 4 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-04 | 198 | 69 | 4 | 705118a5db366b43ffd3389c60e4cb392ad3f2e6 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_only / Treatment groups by lineage, cell group, cell type | 2.52e-04 | 198 | 69 | 4 | d205dfcfe1f20e1e21bf84759e723d9e6e610a5c | |
| ToppCell | Caecum-(5)_Dendritic_cell-(50)_cDC2|Caecum / shred on region, Cell_type, and subtype | 2.56e-04 | 199 | 69 | 4 | bf8a10a9db7e8e0a6e2b53747949f442fe0e581e | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-04 | 199 | 69 | 4 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-04 | 199 | 69 | 4 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-04 | 199 | 69 | 4 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.56e-04 | 199 | 69 | 4 | c8bc05dece8b8a87d4a7a3e8112b924e15217de1 | |
| ToppCell | Caecum-Dendritic_cell-cDC2|Caecum / Region, Cell class and subclass | 2.56e-04 | 199 | 69 | 4 | 944c567307082dd54dc141e93965d46f4ec8bc1f | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-04 | 199 | 69 | 4 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-04 | 199 | 69 | 4 | 78b245d40c1e169ff2d26907b63d732e34529c5f | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.56e-04 | 199 | 69 | 4 | 8e1e95c3a4b856415af208be6ad977e575bac189 | |
| ToppCell | cellseq2-Mesenchymal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.61e-04 | 200 | 69 | 4 | 6b558cce0d6047c7e85f428adff80c5ca3084ea4 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 69 | 4 | 6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Smooth_Muscle_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.61e-04 | 200 | 69 | 4 | 55ac281901309e30978da1f7489386e54489721e | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 69 | 4 | 410b1a31de21c57d87ca2104f61cf4a7d4dd2f30 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 69 | 4 | b0ba486b55be18a4236bd2644f02352651f4b1fe | |
| ToppCell | mild-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.61e-04 | 200 | 69 | 4 | ca0a08bf162c954f037a56aa0cbb8b5d7c6ffec0 | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.17e-06 | 199 | 68 | 7 | 6020_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.27e-05 | 172 | 68 | 6 | 2330_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.27e-05 | 172 | 68 | 6 | 5903_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.22e-05 | 190 | 68 | 6 | 6979_UP | |
| Drug | Gabapentin [60142-96-3]; Up 200; 23.4uM; HL60; HT_HG-U133A | 2.43e-05 | 193 | 68 | 6 | 2731_UP | |
| Drug | Sparteine (-) [90-39-1]; Up 200; 17uM; MCF7; HT_HG-U133A | 2.72e-05 | 197 | 68 | 6 | 4391_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.80e-05 | 198 | 68 | 6 | 6053_DN | |
| Drug | AG-028671 [847803-03-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.80e-05 | 198 | 68 | 6 | 6587_DN | |
| Disease | HbA1c measurement, polycystic ovary syndrome | 4.76e-05 | 5 | 65 | 2 | EFO_0000660, EFO_0004541 | |
| Disease | Adult Hodgkin Lymphoma | 3.67e-04 | 13 | 65 | 2 | C0220597 | |
| Disease | Hodgkin lymphoma, lymphocyte depletion | 3.67e-04 | 13 | 65 | 2 | C0152267 | |
| Disease | Mixed Cellularity Hodgkin Lymphoma | 3.67e-04 | 13 | 65 | 2 | C0152266 | |
| Disease | hematologic cancer (implicated_via_orthology) | 3.67e-04 | 13 | 65 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | Lymphocyte Rich Classical Hodgkin Lymphoma | 3.67e-04 | 13 | 65 | 2 | C1266194 | |
| Disease | Nodular Lymphocyte Predominant Hodgkin Lymphoma | 3.67e-04 | 13 | 65 | 2 | C1334968 | |
| Disease | neutrophil-to-lymphocyte ratio | 7.51e-04 | 185 | 65 | 4 | EFO_0008447 | |
| Disease | Hodgkin Disease | 1.07e-03 | 22 | 65 | 2 | C0019829 | |
| Disease | Ovarian Serous Adenocarcinoma | 1.17e-03 | 23 | 65 | 2 | C1335177 | |
| Disease | C-reactive protein measurement | 1.26e-03 | 1206 | 65 | 9 | EFO_0004458 | |
| Disease | mean arterial pressure, alcohol drinking | 1.34e-03 | 98 | 65 | 3 | EFO_0004329, EFO_0006340 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLSRPSSCPGTSSPG | 36 | Q75L30 | |
| SSGPGAPLEPSTLGS | 26 | Q96MC4 | |
| TAGRPSGSTPLGPLA | 56 | Q8IVW6 | |
| PSERGTPGPDSSGSL | 361 | Q9UBC2 | |
| SSSLLGPPGTSALPR | 576 | P55198 | |
| PGSAPSGGPSRLSSS | 691 | Q15059 | |
| LSSAPDGSTPPASRG | 211 | Q7RTU5 | |
| PPCGPRDLGDGSSST | 171 | Q15834 | |
| SRTDSPPSSLDGPAG | 451 | Q86SQ6 | |
| ALGPTPGPGSSELRS | 16 | Q9BXJ3 | |
| PGPPSLSSGSGSREL | 366 | Q99490 | |
| PTSRGLSSGTLPGPG | 441 | P48546 | |
| SGTTLRPPTSSTPGG | 506 | Q9HBB8 | |
| PSLGPDGTRTFSLSP | 466 | O14529 | |
| LTALTAPGPGSGSRP | 306 | P32239 | |
| PLPGSGAKPLDSTGT | 231 | Q9Y2E6 | |
| GSSLSPSPAPSQRDG | 121 | A7MBM2 | |
| GSPLPSRTGSLTDEP | 276 | Q8IWY9 | |
| PPAASGGSRSSSSPL | 306 | Q96B01 | |
| TGGLDLPSPPTGASL | 366 | Q15113 | |
| PGDDSSMGGRPSSPL | 26 | Q86XR2 | |
| VRPSDSGLPSESGPS | 376 | Q9GZQ6 | |
| SGLPSESGPSSGAPR | 381 | Q9GZQ6 | |
| LGDLRSSSPGPTGQP | 26 | Q00325 | |
| PPGRDSSSLAGTPSD | 781 | O75145 | |
| PATTGALSTGSPPRE | 966 | P56645 | |
| SSLSGSGDGRPPPLL | 1881 | Q9H6A9 | |
| PSPSDSSALTDGGLP | 956 | Q9H5P4 | |
| PPPSSGRASLSSLLG | 211 | P39060 | |
| GSSRPPAPSSHGSLA | 746 | Q9P1Y6 | |
| SAPGSSPERSGPGLL | 841 | Q9P1Y6 | |
| LPGLLTPPSGEGGSS | 386 | Q05215 | |
| LSLSPPSGLDSPNGS | 81 | Q9BZE0 | |
| SDSLPGSPTHGLPAR | 1121 | Q9Y2H9 | |
| APGLPSATPTASGDR | 2181 | P16112 | |
| TPGPTPRSTLGSSEA | 381 | Q86XN7 | |
| SGLFPPSSLLGGSPT | 231 | P23771 | |
| GSSSHLSPRPPLGSS | 826 | Q8NHM5 | |
| SAGTLPGPGASLPSS | 1326 | Q9Y6J0 | |
| RSPTPPSSAGLGSNS | 816 | Q8IWX8 | |
| TLSGLDGPSTPGPFS | 411 | P28324 | |
| PSSSPPTSVLGLGGL | 196 | Q16829 | |
| PDSRRGSSSSGDPPL | 1101 | O95180 | |
| TPVDPLGPSTGSSRG | 181 | Q5VV67 | |
| PSPRKSSGDSGGPST | 966 | Q8NG08 | |
| GLTAAPTSLGSSDPP | 181 | Q9BUB5 | |
| AGTSGDSGPPDRSPL | 461 | O43189 | |
| AASRPSPSGGDSVLP | 1201 | Q9Y6R4 | |
| SLPSPPSRSSSSGEG | 276 | Q92570 | |
| PGPLPLVSGRSASSS | 771 | Q5T011 | |
| GPSRSSEDLAGPLPS | 121 | Q9NRF2 | |
| SESRGPGPRPSPASS | 451 | Q8NDX1 | |
| LPPRSGSTSISAPTG | 141 | O15357 | |
| TLGAGTTRSPGSPPT | 961 | A1L4H1 | |
| GPPGPALTSDSSREL | 1016 | A1L4H1 | |
| SDAGPPPISRSGAAS | 186 | Q86SQ0 | |
| RSPSSAGSPRSPGTP | 26 | E7ERA6 | |
| GPSDLSLLSLPPGTS | 71 | Q9Y6X2 | |
| SVPLPSGSTSSPGRG | 326 | Q15036 | |
| SSPGSLSAPRSPSRG | 21 | M0QZC1 | |
| SLPGSELPSSRPEGS | 2271 | O15027 | |
| RPPPSGGLSSSSDSE | 1911 | Q15772 | |
| SPGSSPRSSPRPEGT | 2941 | Q15772 | |
| PPSSGSLPSQDLLGT | 721 | Q8IWN7 | |
| SFSGLPSGRRTSPPP | 186 | P26651 | |
| GRAPGSASGPLSPSL | 86 | Q96BV0 | |
| DPGLSSPGPLSSSGG | 121 | Q9NS37 | |
| SSVGRPSSDPGLSPT | 216 | P28908 | |
| PTSGAPGSPGTLALR | 576 | Q96F45 | |
| PGPSSPRTSRGALSP | 61 | Q0IIN9 | |
| GSPSPLGDTASGLPD | 361 | Q9Y2B5 | |
| GSGLGTPLSPSPASG | 981 | Q5JPB2 | |
| GPLGSSEGSRPSASP | 496 | Q9BU19 | |
| PRPSSGLTVASPGSA | 81 | Q6ZQT7 | |
| LTPSPLSGPGGSSLL | 3196 | O14686 |